| Age (year) |
56.20±8.56 |
56 |
36-78 |
52.38±10.45 |
53 |
25-71 |
0,053 |
| Body Mass Index (kg/m²) |
29.67±4.05 |
30 |
20-38 |
28.04±3.76 |
28 |
20-38 |
0,014 |
| RA disease duration (year) |
12.70±8.52 |
10 |
1-30 |
7.60±6.58 |
6 |
0,8-28 |
0,001 |
| Duration of Biologic agents usage (year) |
3.01±1.90 |
3 |
0,5-10 |
2.75±1.84 |
3 |
0,5-8 |
0,437 |
| Pain Visual Analog Scale (0-100 mm) |
55.57±22.10 |
50 |
10-90 |
35.40±18.42 |
35 |
10-80 |
<0.001 |
| Patient Global Assessment (0-100 mm) |
51.21±20.11 |
50 |
10-90 |
33.20±16.95 |
30 |
10-80 |
<0.001 |
| HAQ score (0-3) |
0.85± 0.70 |
0,72 |
0-2,4 |
0.21±0.32 |
0,10 |
0-1,4 |
<0.001 |
| Disease Activity Score in 28 joints |
4.04±1.34 |
3,92 |
2.47-7.54 |
2.98±0.99 |
2,95 |
1.27-5.76 |
<0.001 |
| FES-I score (0-64) |
27.22±8.00 |
25 |
16-51 |
17.82±3.37 |
18 |
0-26 |
<0.001 |
| One Leg Stand Test (seconds) |
9.92±10.56 |
5 |
1-30 |
22.64±10.58 |
30 |
1-30 |
<0.001 |
| Berg Balance Scale score (0-56) |
44.67±9.44 |
44 |
8-56 |
54.02±3.72 |
56 |
41-56 |
<0.001 |
| 10-Meter Walk Test (seconds) |
8.78±4.36 |
8 |
5-30 |
6.18±0.22 |
6 |
4-10 |
<0.001 |
| Beck Anxiety Index score (0-63) |
12.81±7.40 |
11,5 |
0-37 |
6.68±5.48 |
5 |
0-20 |
<0.001 |
| Beck Depression Index score (0-63) |
15.12±6.83 |
16 |
0-28 |
8.62±6.20 |
8 |
0-22 |
<0.001 |
| ESR (0-20 mm/h) |
31.80±18.46 |
32 |
3-92 |
25.80±21.78 |
22 |
3-101 |
0,025 |
| C-reactive protein (0-35 mg/dL) |
2.42±6.09 |
0,58 |
0.05-42.10 |
4.87±13.94 |
0,6 |
0,11-82 |
0,947 |
| SD: Standard deviation; Min: Minimum; Max: Maximum; RA: Rheumatoid arthritis; HAQ: Health Assessment Questionnaire; FES-I: Fall Efficacy Scale International-I; ESR: Erythrocyte sedimentation rate; P value <0.05 significant. |
